scholarly journals Dietary Whole Egg Consumption Attenuates Body Weight Gain and Is More Effective than Supplemental Cholecalciferol in Maintaining Vitamin D Balance in Type 2 Diabetic Rats

2017 ◽  
pp. jn254193 ◽  
Author(s):  
Cassondra J Saande ◽  
Samantha K Jones ◽  
Kaylee E Hahn ◽  
Carter H Reed ◽  
Matthew J Rowling ◽  
...  
2019 ◽  
Vol 149 (10) ◽  
pp. 1766-1775 ◽  
Author(s):  
Cassondra J Saande ◽  
Joseph L Webb ◽  
Paige E Curry ◽  
Matthew J Rowling ◽  
Kevin L Schalinske

ABSTRACT Background We previously reported that a whole-egg–based diet attenuated weight gain in rats with type 2 diabetes (T2D) and more effectively maintained vitamin D status than an equivalent amount of supplemental cholecalciferol. Objectives The objective of this study was to determine the lowest dose of whole egg effective at maintaining vitamin D homeostasis and attenuating the obese phenotype in T2D rats. Methods Zucker diabetic fatty (ZDF) rats (n = 40; age 6 wk; prediabetic) and their lean controls (n = 40; age 6 wk) were randomly assigned to a diet containing 20% casein (CAS) or 20%, 10%, 5%, or 2.5% protein from whole egg (20% EGG, 10% EGG, 5% EGG, and 2.5% EGG, respectively). All diets contained 20% total protein (wt:wt). All rats received their respective diets for 8 wk, at a stage of growth and development that translates to adolescence in humans, until 14 wk of age, a point at which ZDF rats exhibit overt T2D. Weight gain was measured 5 d/wk, and circulating 25-hydroxyvitamin D [25(OH)D] was measured by ELISA. Mean values were compared by 2-factor ANOVA. Results The 20% EGG diet maintained serum 25(OH)D at 30 nmol/L in ZDF rats, whereas the 10%, 5%, and 2.5% EGG diets did not prevent insufficiency, resulting in mean serum 25(OH)D concentrations of 24 nmol/L in ZDF rats. Body weight gain was reduced by 29% (P < 0.001) and 31% (P < 0.001) in ZDF rats consuming 20% and 10% EGG diets, respectively, and by 16% (P = 0.004) and 12% (P = 0.030) in ZDF rats consuming 5% and 2.5% EGG diets, respectively, compared with CAS. Conclusions Whole-egg–based diets exerted a dose-dependent response with respect to attenuating weight gain. These data could support dietary recommendations aimed at body weight management in individuals predisposed to obesity and T2D.


2015 ◽  
Vol 64 (1) ◽  
pp. 120-124 ◽  
Author(s):  
Samantha K. Jones ◽  
Gar Yee Koh ◽  
Matthew J. Rowling ◽  
Kevin L. Schalinske

2003 ◽  
Vol 3 (1) ◽  
pp. 56-59 ◽  
Author(s):  
Kaori Inoue ◽  
Hiroshi Ikegami ◽  
Tomomi Fujisawa ◽  
Maki Shintani ◽  
Yumiko Kawabata ◽  
...  

Diabetes Care ◽  
2006 ◽  
Vol 29 (8) ◽  
pp. 1826-1832 ◽  
Author(s):  
J. Martin ◽  
Z. Q. Wang ◽  
X. H. Zhang ◽  
D. Wachtel ◽  
J. Volaufova ◽  
...  

2021 ◽  
Author(s):  
PRASENJIT MITRA ◽  
Rathin Bauri ◽  
Shilpak Bele ◽  
Jhansi Edelli ◽  
Sourav Dasadhikari ◽  
...  

We report the discovery of a novel glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor dual agonist that shows balanced agonism towards both the incretin receptor. The dual agonism of GLP-1 and GIP receptor was achieved by replacing the tryptophan cage of exendin-4 with the C- terminal undecapeptide sequence of oxyntomodulin along with a single amino acid substitution from histidine to tyrosine at the amino terminus of the peptide. The structural modification places lysine 30 of the novel incretin agonist in frame with the corresponding lysine residue in the native GIP sequence. The novel incretin agonist, named I-M-150847, promotes robust glucose-stimulated insulin exocytosis in cultured pancreatic beta cells. Chronic administration of I-M-150847 to mice fed on the high-fat diet improves glucose tolerance, decreases food intake, decreases visceral adiposity and body weight gain demonstrating its therapeutic potential in ameliorating type 2 Diabetes and Obesity.


Sign in / Sign up

Export Citation Format

Share Document